BBV Dried Blood Spot EQA/PT Pilot Study

Dried blood spot testing for blood borne virus diagnosis is typically used to support screening in settings where plasma or serum sampling and cold storage is challenging.

The pilot EQA scheme will assess the performance of laboratories in the detection of hepatitis C virus (HCV), hepatitis B virus (HBV) and human immunodeficiency virus (HIV) from dried blood spots.

Total Number of Challenges: 1
Number of Panel Members: 10
Distribution / Testing Period: Q3

 

Sample NA Target Source Cultured and/or Clinical material
Matrix Panel Format Dried Blood Spots
Panel Member Target Range Covering clinical range
Panel Member Sample Volume 2 x 50 µl
Panel Sample Pre-treatment Requirement Extraction from dried blood spot.
Panel Analysis Type Qualitative. Quantitative for information purposes only
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions Ambient
SKU: QAM254228_1 Categories: , , Tags: ,

$1,258.40